Ultimate magazine theme for WordPress.

ACPN Issues 24-Hour Ultimatum to Edo Consumer Protection Boss Over Camosunate Ban Claim

0 11

​The Association of Community Pharmacists of Nigeria (ACPN) has issued a 24-hour ultimatum to the Chairman of the Edo State Consumer Protection Committee, Mr. Osaro Culture Iyamu, demanding verifiable proof to back his reported claim that the antimalarial drug, Camosunate, is banned in Nigeria.

​In a strongly worded statement jointly signed by its National Chairman, Pharm. Ambrose Igwekamma Ezeh, and National Secretary, Obigariel Ikwu, the association warned that failure to produce authentic regulatory evidence within the stipulated timeframe would trigger legal action.

​The ACPN condemned what it termed “regulatory overreach, unsubstantiated pharmaceutical claims, and questionable enforcement practices” under Iyamu’s leadership, insisting that while the fight against counterfeit and substandard drugs is vital, it must strictly adhere to the law and professional competence.

​Refuting the ban claim, the pharmacists noted that official checks on the National Agency for Food and Drug Administration and Control (NAFDAC) Greenbook confirm that Camosunate Children Powder (Registration Number: 04-7908)—manufactured by Front Pharmaceuticals PLC and marketed by Geneith Pharmaceuticals Limited—is an active, registered medicinal product. According to the association, the drug’s registration was approved on November 26, 2025, and remains valid until November 25, 2030.

​”This is an official regulatory record, not industry speculation or personal opinion,” the ACPN stated, challenging Iyamu to produce an authentic NAFDAC prohibition, suspension, or cancellation notice within 24 hours, or tender an immediate public retraction and apology.

​The association also faulted a recent enforcement raid on ALSO CARE Pharmacy in the Evbuodia community along Airport Road, Benin City, demanding transparent disclosure of the allegedly seized items and independent regulatory proof that they were counterfeit or prohibited. It maintained that licensed pharmacy practitioners must not be publicly condemned based on unverified allegations.

​Challenging the committee’s statutory jurisdiction to regulate pharmacies, the ACPN cited Sections 22, 31, and 32 of the Pharmacy Council of Nigeria (PCN) Act 2022, Section 5 of the NAFDAC Act, and Sections 7 and 8 of the Counterfeit and Fake Drugs Act. It argued that a general consumer protection mandate does not confer specialized pharmaceutical enforcement powers without proper legal constitution as a State Task Force approved by the Federal Minister of Health.

​Consequently, the ACPN outlined six core demands, including:

  • ​Immediate production of authentic NAFDAC documentation substantiating the Camosunate ban, or a public apology.
  • ​Disclosure by the Edo State Government of the legal instrument establishing the consumer protection committee, alongside any Federal Ministerial approval constituting it as a State Task Force.
  • ​An immediate halt to pharmaceutical enforcement activities conducted without statutory authority, and full respect for the constitutional mandates of NAFDAC and the PCN.

​The association appealed directly to the Edo State Governor, Senator Monday Okpebholo, to urgently intervene to ensure institutional accountability and prevent jurisdictional conflicts that could erode public confidence in the state’s healthcare system.

​Reaffirming its commitment to safeguarding public health, the ACPN vowed to use every legitimate legal channel to protect licensed pharmacists from administrative arbitrariness and regulatory intimidation.

Leave A Reply

Your email address will not be published.